COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®
11/03/2019
SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851, part of a grant providing [...]
Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
11/03/2019
-- Principia and AbbVie mutually agree to end collaboration -- -- Preclinical stage program focused on development of oral immunoproteasome inhibitors to treat inflammation and autoimmune disorders -- SOUTH SAN [...]
ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
11/03/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
VBL Therapeutics to Present at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women's Cancer on March 18
11/03/2019
TEL AVIV, Israel, March 11, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth
11/03/2019
EMERYVILLE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Agile Therapeutics to Present at Upcoming Investor Conferences
11/03/2019
PRINCETON, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Senior Vice President and Chief Financial Officer, Scott Coiante will [...]
Eidos Therapeutics to Present at 31st Annual ROTH Conference
11/03/2019
SAN FRANCISCO, March 11, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) today announced that management is scheduled to participate in a fireside chat regarding Eidos at the 31 st Annual ROTH [...]
MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG™ Device
11/03/2019
IRVINE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) a platform neurosurgery company developing products designed to deliver navigation, ablation, deep brain stimulation, aspiration, [...]
AlloSure Heart Clinical Validation Published in Leading Transplant Journal
11/03/2019
Alongside AlloSure Heart Validation, CareDx advances SHORE enrollment BRISBANE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, [...]
Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria
11/03/2019
CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular [...]
Donnelly Group Confirms Plan for Cannabis Retail Chain, Hobo Recreational Cannabis Store
11/03/2019
Nine private recreational stores set to open nationwide beginning April 2019 VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Donnelly Group, the Canadian hospitality company, today confirms its new [...]
aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
11/03/2019
Partnership to accelerate development of IND candidates from tRNA synthetases in aTyr’s pipeline aTyr eligible to receive up to $17 million in potential option fees SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- aTyr [...]
Advantis Corp. Meeting With N2Pack to Expand Partnership
11/03/2019
NEWPORT BEACH, CA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced a planned meeting with N2Pack’s executives at their corporate headquarters in Idaho. Advantis CEO [...]
UAHC Subsidiary American Sustainable Rubber Company, LLC Assigned Grant Funding from The Ohio State University “SEEDS” Program
11/03/2019
CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced its wholly-owned subsidiary American Sustainable Rubber Company, [...]
Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
11/03/2019
Completed end-of-Phase 2 FDA meeting for molluscum contagiosum Meeting minutes received and support second quarter 2019 pivotal Phase 3 initiation Finalizing establishment of Irish entity to enable EU regulatory and [...]
Tauriga Sciences, Inc. Officially Launches its E-Commerce Site for the Sale of its CBD Infused Chewing Gum: Tauri-Gum
11/03/2019
Website: WWW.TAURIGUM.COM NEW YORK, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development [...]
Tyme Technologies To Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing metabolic-based cancer therapies, announced that management will present a corporate [...]
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
11/03/2019
FRAMINGHAM, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome
11/03/2019
~ Extended Evaluation Phase Meets Objective of Showing Positive Long-Term Benefit-Risk Profile of RECORLEV™ (levoketoconazole) ~ ~ Favorable Liver-Related Findings: No Patients Experienced an Increase in Either Alanine [...]

Pages